Valeant Pharma (VRX) Reports Q3 EPS of $2.11

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. DOX
4. VRTX
5. CHKP
6. CRWD
7. ON
8. INSP
9. HNGE
10. AMD

Go back to Valeant Pharma (VRX) Reports Q3 EPS of $2.11

Valeant Pharmaceuticals (VRX) PT, Estimates Raised at Jefferies on Strong Q3

October 21, 2014 8:00 AM EDT

Jefferies analyst David Steinberg reiterated a Buy rating and boosted his price target on Valeant Pharmaceuticals (NYSE: VRX) to $149.00 (from $141.00) following strong Q3 results.

Steinberg commented, "Valeant reported a strong Q3 as expected. While revs of $2.06B were slightly dampened due... More

Valeant Pharma (VRX) Posts Strong Q3 Results, Bumps Outlook Higher; Aegis Capital Maintains at 'Buy'

October 20, 2014 9:55 AM EDT

Aegis Capital affirms its Buy rating and $180 price target on Valeant Pharmaceuticals (NYSE: VRX) following Q3 results and guidance update.

Analyst Ram Selvaraju commented, This morning, Valeant reported third quarter 2014 financial results. The firm delivered cash EPS of $2.11 per share vs. our projection of... More